Longevity Startups

Momentum TX develops therapeutics targeting the aging process to treat age-related conditions of the central and peripheral nervous systems, with a focus on neurodegeneration. It uses in silico, in vitro, and in vivo methods and proteomics data to identify drug targets that restore protein configurations altered in the aged brain.

1 investor

Monarch Clubs is a wellness company that combines health education, technology, and accessibility to provide integrated health and lifestyle guidance. The company serves individuals seeking comprehensive wellness solutions through a multi-disciplinary, globally connected approach.

1 investor

MORROW builds a health community and physical space combining licensed longevity medical services with AI and technology-based protocols to help people improve their long-term health and habits. Based in Singapore, it focuses on closing the gap between lifespan and healthspan for aging adults.

1 investor

My Dementia Companion is a digital health platform designed to support professional carers, family members, and friends caring for people with dementia. The company was created by carers, health professionals, and innovators in Australia.

1 investor

Myospan develops smarter protein systems and science-based guidance focused on muscle longevity and healthy aging, targeting adults 35+ who want to maintain strength, recovery, and mobility. It offers a coaching program (the Muscle Longevity System), a podcast, and educational guides on nutrition, amino acids, and resistance training.

1 investor

ImmunityBio develops investigational immunotherapies that activate both innate and adaptive immune responses—stimulating NK cells, T cells, macrophages, and dendritic cells—to treat cancer and infectious diseases. The company works on cell therapies and potential cancer vaccines intended to reduce reliance on high-dose chemotherapy.

1 investor

Neotis develops immunotherapies to counteract age-related tissue decline by directing the immune system, with an initial focus on fibrotic disease. The company combines expertise in immunology, senescence, and biomarker development.

1 investor

Neuro-Bio is an Oxfordshire-based biotech company developing a biomarker and a diagnostic for Alzheimer's disease based on a novel hypothesis of the neurodegenerative process, originating from research at Oxford University. It also pursues neuroprotection approaches, with its first patent covering chemical composition of matter.

1 investor

NeuroAge offers multi-modal brain health testing that combines cognitive games, volumetric MRI, whole-genome sequencing, and blood biomarker tests to measure "brain age" and dementia risk for individuals concerned about neurodegenerative disease. It provides a unified dashboard, personalized recommendations, and brain training aimed at early detection of Alzheimer's and cognitive decline.

1 investor

Neuronity develops therapies that enhance immune cell activity in the aging brain to prevent neurodegenerative disease progression. The company targets patients with age-related neurological conditions.

1 investor

New Frontier Bio is a biotechnology company with a cross-functional management team experienced in start-ups, science, strategy, and M&A across healthcare, biotechnology, and cosmetics.

1 investor

Niraamaya Life is an Indian luxury hospitality and wellness brand operating retreats and residences across serene locations in India, combining holistic health programs with hospitality. It offers wellness retreats, Ayurveda-based self-care products, online wellness programs, and personalized preventive wellness and longevity experiences.

1 investor

NOHO is a concierge wellness membership service that designs personalized peptide protocols based on a member's biology, health history, and goals, with support from clinicians and a dedicated concierge team. It sources peptides from FDA-inspected facilities and focuses on health optimization, performance, recovery, and vitality.

1 investor

Eledon develops tegoprubart, an anti-CD40L antibody immunosuppressant for organ transplant recipients, aimed at preventing transplant rejection and extending organ longevity. The company is conducting clinical trials in kidney transplantation with expansion into liver transplants and xenotransplantation.

1 investor

nuAura provides advanced blood test interpretation focused on longevity and preventive health, offering deeper biomarker analysis beyond standard reference ranges. The service is designed for individuals seeking to understand and optimize their metabolic health, hormonal balance, and micronutrient status.

1 investor

Nuchido develops Nuchido TIME+, an NAD+ boosting dietary supplement aimed at supporting cellular repair and healthy aging in consumers. The company focuses on science-backed longevity and wellness products for people seeking to counter age-related declines in energy, cognition, and skin health.

1 investor

Nula Therapeutics develops targeted small-molecule medicines that correct how the nuclear envelope regulates gene expression and cellular function. The company focuses on treating age-related diseases including metabolic dysfunction, neurodegeneration, and cancer, and on extending healthspan.

1 investor

Nuvig Therapeutics is a biotech company developing immune-modulating therapies for autoimmune and chronic inflammatory diseases, using an endogenous regulatory mechanism intended to treat inflammation without compromising broader immune function. It targets patients with autoimmune conditions.

1 investor

Okava develops medicines for dogs and cats by adapting established human pharmaceuticals for veterinary use, targeting conditions such as obesity, diabetes, arthritis, and chronic inflammation. The company operates in the animal health and pet pharmaceutical sector.

1 investor

Oligomerix is a biopharmaceutical company developing therapeutic compounds, with leadership focused on advancing drug candidates through clinical development stages.

1 investor

OmniActive develops scientifically validated, nature-based ingredients for the nutraceutical and natural products industry. The company specializes in extracting and delivering innovative ingredient solutions sourced from spices and natural materials.

1 investor

One Senior Care operates as a PACE (Programs of All-Inclusive Care for the Elderly) provider, delivering comprehensive healthcare and social services to seniors in rural and Appalachian communities. The organization addresses healthcare disparities through community-based programs that reduce access barriers and financial hardship for underserved elderly populations.

1 investor

A biotechnology company focused on developing therapeutics related to genetic regulation of longevity and aging processes, with expertise in drug development and clinical trials.

1 investor

OptiChroniX is a Swiss digital health company whose Rejuvify system provides a daily prioritization framework to preserve functional muscle and lean mass during weight loss, aging, and lifestyle changes. It uses real-world data such as body composition, activity, and behavior to focus users each day on protein intake, resistance stimulus, or recovery.

1 investor